![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 7, 4639-4645, February 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Estrogen receptor
Regulation of Estrogen Receptor
-mediated Transcription by a
Direct Interaction with Protein Phosphatase 2A*
,
,
,
,
Department of Medicine and Molecular
Cardiology Research Institute, New England Medical Center Hospitals,
Inc., Tufts University School of Medicine, Boston, Massachusetts 02111, the ¶ Department of Biochemistry, Emory University School of
Medicine, Rollins Research Center, Atlanta, Georgia 30322, and the
§ Tufts University School of Veterinary Medicine,
North Grafton, Massachusetts 01536
(ER
) mediates the
effects of estrogen by altering gene expression following hormone
binding. It has recently been shown that kinase-mediated
phosphorylation of ER
also transcriptionally activates the receptor
in the absence of estrogen. We now report that
ER
-dependent gene expression also is regulated by
protein phosphatase 2A (PP2A). ER
co-immunoprecipitates with
enzymatically active PP2A. ER
binds directly to the catalytic
subunit of PP2A, which dephosphorylates serine 118 of the receptor.
Amino acids 176-182 in the A/B domain of ER
are required for the
interaction between PP2A and the receptor. Phosphatase inhibition
disrupts the ER
-PP2A complex and induces formation of an
ER
-activated mitogen-activated protein kinase complex,
phosphorylation of ER
on serine 118, and transcriptional activation.
These findings demonstrate that estrogen receptors exist in complexes
with phosphatases as well as kinases. We propose a new model of
ligand-independent activation of estrogen receptors in which the level
of phosphorylation of ER
, and hence its transcriptional activation,
is determined by the net effect of these counterregulatory pathways.
*
This work was supported in part by National Institutes of
Health Grant HL61290 (to R. H. K.). Under agreements between
Upstate Biotechnology Inc. and Emory University and Calbiochem and
Emory University, D. Pallas is entitled to a share of sales royalty received by the University from these companies. In addition, this same
author serves as a consultant to Upstate Biotechnology Inc. The terms
of this arrangement have been reviewed and approved by Emory University
in accordance with its conflict of interest policies.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Established Investigator of the American Heart Association. To
whom correspondence should be addressed: Molecular Cardiology Research
Center, Tufts-New England Medical Center, 750 Washington St., Box 80, Boston, MA 02111. Tel.: 617-636-8776; Fax: 617-636-1444; E-mail:
rkaras@lifespan.org.
This article has been cited by other articles:
![]() |
B. Tan, X. Long, H. Nakshatri, K. P Nephew, and R. M Bigsby Striatin-3{gamma} inhibits estrogen receptor activity by recruiting a protein phosphatase J. Mol. Endocrinol., May 1, 2008; 40(5): 199 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Yi, Z. Y. Cai, D. F. Covey, and J. W. Simpkins Estrogen Receptor-Independent Neuroprotection via Protein Phosphatase Preservation and Attenuation of Persistent Extracellular Signal-Regulated Kinase 1/2 Activation J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1188 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Ing, D. A. Massuto, and L. A. Jaeger Estradiol Up-regulates AUF1p45 Binding to Stabilizing Regions within the 3'-Untranslated Region of Estrogen Receptor {alpha} mRNA J. Biol. Chem., January 18, 2008; 283(3): 1764 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lecuona, L. A. Dada, H. Sun, M. L. Butti, G. Zhou, T.-L. Chew, and J. I. Sznajder Na,K-ATPase {alpha}1-subunit dephosphorylation by protein phosphatase 2A is necessary for its recruitment to the plasma membrane FASEB J, December 1, 2006; 20(14): 2618 - 2620. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Sarwar, J-S Kim, J Jiang, D Peston, H D Sinnett, P Madden, J M Gee, R I Nicholson, A E Lykkesfeldt, S Shousha, et al. Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression. Endocr. Relat. Cancer, September 1, 2006; 13(3): 851 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Proia, B. W. Nannenga, L. A. Donehower, and N. L. Weigel Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function J. Biol. Chem., March 17, 2006; 281(11): 7089 - 7101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Belcher, H. H. Le, L. Spurling, and J. K. Wong Rapid Estrogenic Regulation of Extracellular Signal- Regulated Kinase 1/2 Signaling in Cerebellar Granule Cells Involves a G Protein- and Protein Kinase A-Dependent Mechanism and Intracellular Activation of Protein Phosphatase 2A Endocrinology, December 1, 2005; 146(12): 5397 - 5406. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Keen, Q. Zhou, B. H. Park, C. Pettit, K. M. Mack, B. Blair, K. Brenner, and N. E. Davidson Protein Phosphatase 2A Regulates Estrogen Receptor {alpha} (ER) Expression through Modulation of ER mRNA Stability J. Biol. Chem., August 19, 2005; 280(33): 29519 - 29524. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gburcik, N. Bot, M. Maggiolini, and D. Picard SPBP Is a Phosphoserine-Specific Repressor of Estrogen Receptor {alpha} Mol. Cell. Biol., May 1, 2005; 25(9): 3421 - 3430. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lu, D. C. Pallas, H. K. Surks, W. E. Baur, M. E. Mendelsohn, and R. H. Karas Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor {alpha} PNAS, December 7, 2004; 101(49): 17126 - 17131. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Patten, I. Pourati, M. J. Aronovitz, J. Baur, F. Celestin, X. Chen, A. Michael, S. Haq, S. Nuedling, C. Grohe, et al. 17{beta}-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling Circ. Res., October 1, 2004; 95(7): 692 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ikeda, S. Ogawa, T. Tsukui, K. Horie-Inoue, Y. Ouchi, S. Kato, M. Muramatsu, and S. Inoue Protein Phosphatase 5 Is a Negative Regulator of Estrogen Receptor-Mediated Transcription Mol. Endocrinol., May 1, 2004; 18(5): 1131 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Le Moellic, A. Ouvrard-Pascaud, C. Capurro, F. Cluzeaud, M. Fay, F. Jaisser, N. Farman, and M. Blot-Chabaud Early Nongenomic Events in Aldosterone Action in Renal Collecting Duct Cells: PKC{alpha} Activation, Mineralocorticoid Receptor Phosphorylation, and Cross-Talk with the Genomic Response J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1145 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tujague, J. S. Thomsen, K. Mizuki, C. M. Sadek, and J.-A. Gustafsson The Focal Adhesion Protein Vinexin {alpha} Regulates the Phosphorylation and Activity of Estrogen Receptor {alpha} J. Biol. Chem., March 5, 2004; 279(10): 9255 - 9263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |